Three things you need to know in the financial markets today from investment writer, Tony Cross.
#1. ScS delay to full year results
There’s a note from ScS LON:SCS advising of a two week delay in the publication of their full year results. Details are scant, with the board simply stating that the extra time is required for finalisation and that numbers will still be in line with the forecasts posted in the trading update issued two months ago. Management are putting up a robust defence here, but how will this map out for share price action in the short term?
- Three Quick Facts: Aston Martin Lagonda, Next and GSK
- Companies Reporting: McDonalds, Aston Martin, GSK, Next
- Three Quick Facts: GSK, Great Portland Estates, N Brown
#2. Chill Brands distribution agreement with WH Smiths
Chill Brands LON:CHLL may only have a market cap of £14m but this morning they have announced that WH Smith has signed a distribution agreement with the company for the sale of its nicotine free vape products. Chill has now secured orders worth £350,000 for its ZERO product since the start of August.
#3. GSK strikes significant China deal
Pharma giant GSK LON:GSK has announced a partnership with Zhifei of China to significantly extend the distribution of its Shingrix vaccine in the local market. The plan is that Zhifei will purchase some £2.5bn worth of the vaccine over a three year period, with the sales phased to grow over the contract’s life. The partnership supports GSK’s commitment to double global Shingrix sales to more than £4bn by 2026. The partnership also covers potential future development of RSV vaccinations.
